Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp created
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

753958

	human indexable
	published
	registered interest
	answer date	02/08/2017
	date	19/07/2017
	date tabled	19/07/2017
	answering body	Department of Health
	question status	Tabled
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	ddp created	19/07/2017 22:26:10 19/07/2017 22:26:10
	ddp modified	19/07/2017 22:26:10 31/07/2017 14:11:05
	hansard heading	Radioisotopes: Imports
	house id	2
	identifier	HL1104
	legislature	25277
	parliament number	57
	question first answered	31/07/2017 13:38:56
	question text	Her Majesty's Government (1) what assessment they have made of the potential impact of not reaching agreement with the EU by April 2019 on the supply of the radioisotope molybdenum-99 used to produce technetium-99m which is required for over 80 per cent of diagnostic medicine procedures in the UK; (2) what assessment they have made of the potential impact of delays or disruption to the supply of diagnostic medicine procedures that may result; and (3) what contingency plans they have put in place to mitigate such delays or disruption to that supply after Brexit.
	session	2017/19
	session number	1
	tabling member printed	Lord Mendelsohn
	title	House of Lords Tabled Parliamentary Question 2017/19 HL1104
	type	WrittenParliamentaryQuestion
	uin	HL1104
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4286 label Biography information for Lord Mendelsohn
	publisher	25277
	tabling member	4286 label Biography information for Lord Mendelsohn

753959

	human indexable
	published
	registered interest
	answer date	02/08/2017
	date	19/07/2017
	date tabled	19/07/2017
	ddp created	19/07/2017 22:26:11
	answering body	Department for Exiting the European Union
	question status	Tabled
	answering dept id	203
	answering dept short name	Exiting the European Union
	answering dept sort name	Exiting the European Union
	ddp modified	19/07/2017 22:26:11 02/08/2017 15:11:02
	hansard heading	Radioisotopes: Imports
	house id	2
	identifier	HL1105
	legislature	25277
	parliament number	57
	question first answered	02/08/2017 14:39:06
	question text	Her Majesty's Government what terms they are seeking to agree with the European Union to ensure that no additional delays or restrictions are placed on imports of molybdenum-99 to the UK following the UK's departure from Euratom.
	session	2017/19
	session number	1
	tabling member printed	Lord Mendelsohn
	title	House of Lords Tabled Parliamentary Question 2017/19 HL1105
	type	WrittenParliamentaryQuestion
	uin	HL1105
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	4286 label Biography information for Lord Mendelsohn
	publisher	25277
	tabling member	4286 label Biography information for Lord Mendelsohn

984272

	human indexable
	published
	registered interest
	answer date	23/10/2018
	date	09/10/2018
	date tabled	09/10/2018
	ddp created	09/10/2018 21:06:21
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/10/2018 21:16:17 17/10/2018 16:00:03
	hansard heading	Radioisotopes: Imports
	house id	2
	identifier	HL10480
	legislature	25277
	parliament number	57
	question first answered	17/10/2018 15:28:41
	question text	To ask Her Majesty's Government what progress has been made to secure trade agreements to ensure the security of supply of medical radioisotopes following Brexit.
	session	2017/19
	session number	1
	tabling member printed	Baroness Golding
	title	House of Lords Tabled Parliamentary Question 2017/19 HL10480
	type	WrittenParliamentaryQuestion
	uin	HL10480
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	281 label Biography information for Baroness Golding
	publisher	25277
	tabling member	281 label Biography information for Baroness Golding

829014

	human indexable
	published
	registered interest
	answer date	06/02/2018
	date	23/01/2018
	date tabled	23/01/2018
	ddp created	23/01/2018 21:45:47
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	23/01/2018 22:05:43 01/02/2018 15:54:02
	hansard heading	Radioisotopes: Imports
	house id	2
	identifier	HL4999
	legislature	25277
	parliament number	57
	question first answered	01/02/2018 15:22:50
	question text	To ask Her Majesty's Government what steps they are taking to ensure that the UK radiopharmaceutical supply after leaving Euratom might be relied upon to not have an impact on patients, in terms of (1) timeliness of delivery, and (2) the quantity supplied of radiopharmaceutical supplies produced (a) in the EU, and (b) outside the EU.
	session	2017/19
	session number	1
	tabling member printed	Lord Carlile of Berriew
	title	House of Lords Tabled Parliamentary Question 2017/19 HL4999
	type	WrittenParliamentaryQuestion
	uin	HL4999
	version	1
	written parliamentary question type	Ordinary
	answer	answer
	creator	1138 label Biography information for Lord Carlile of Berriew
	publisher	25277
	tabling member	1138 label Biography information for Lord Carlile of Berriew